Literature DB >> 20710124

Antimicrobial susceptibilities of four species of Mycoplasma isolated in 2008 and 2009 from cattle in Japan.

Ryoko Uemura1, Masuo Sueyoshi, Hiroshi Nagatomo.   

Abstract

We examined the susceptibility in vitro of 99 isolates of Mycoplasma (M. bovirhinis, M. bovis, M. alkalescens and M. bovoculi) and one of Acholeplasma laidlawii collected in 2008 and 2009 from Japanese homebred cattle and cows imported from Australia to 13 antimicrobial agents. Mycoplasma species isolated from homebred cattle were susceptible to spectinomycin and fluoroquinolones but resistant to macrolides, tetracyclines, thiamphenicol and flumequine. Kanamycin, lincomycin and chloramphenicol maintained intermediate effectiveness against these species. The isolates from the imported cows maintained sufficient susceptibility to all antimicrobials examined except for erythromycin and thiamphenicol. These results showed that four species of Mycoplasma isolated from Japanese homebred cattle had obviously higher drug resistance compared with previous reports, even within this decade.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20710124     DOI: 10.1292/jvms.10-0165

Source DB:  PubMed          Journal:  J Vet Med Sci        ISSN: 0916-7250            Impact factor:   1.267


  9 in total

1.  16S rRNA gene mutations associated with decreased susceptibility to tetracycline in Mycoplasma bovis.

Authors:  E Amram; I Mikula; C Schnee; R D Ayling; R A J Nicholas; R S Rosales; S Harrus; I Lysnyansky
Journal:  Antimicrob Agents Chemother       Date:  2014-11-17       Impact factor: 5.191

2.  Development of oriC-Based Plasmids for Mesoplasma florum.

Authors:  Dominick Matteau; Marie-Eve Pepin; Vincent Baby; Samuel Gauthier; Mélissa Arango Giraldo; Thomas F Knight; Sébastien Rodrigue
Journal:  Appl Environ Microbiol       Date:  2017-03-17       Impact factor: 4.792

3.  A GC-Rich Prophage-Like Genomic Region of Mycoplasma bovirhinis HAZ141_2 Carries a Gene Cluster Encoding Resistance to Kanamycin and Neomycin.

Authors:  Inna Lysnyansky; Ilya Borovok
Journal:  Antimicrob Agents Chemother       Date:  2021-01-20       Impact factor: 5.191

4.  Alterations in the Quinolone Resistance-Determining Regions and Fluoroquinolone Resistance in Clinical Isolates and Laboratory-Derived Mutants of Mycoplasma bovis: Not All Genotypes May Be Equal.

Authors:  Dima Khalil; Claire A M Becker; Florence Tardy
Journal:  Appl Environ Microbiol       Date:  2015-12-04       Impact factor: 4.792

5.  Overall decrease in the susceptibility of Mycoplasma bovis to antimicrobials over the past 30 years in France.

Authors:  Anne V Gautier-Bouchardon; Séverine Ferré; Dominique Le Grand; Agnès Paoli; Emilie Gay; François Poumarat
Journal:  PLoS One       Date:  2014-02-04       Impact factor: 3.240

6.  Antibiotic susceptibility profiles of Mycoplasma bovis strains isolated from cattle in Hungary, Central Europe.

Authors:  Kinga M Sulyok; Zsuzsa Kreizinger; Lilla Fekete; Veronika Hrivnák; Tibor Magyar; Szilárd Jánosi; Nóra Schweitzer; Ibolya Turcsányi; László Makrai; Károly Erdélyi; Miklós Gyuranecz
Journal:  BMC Vet Res       Date:  2014-10-25       Impact factor: 2.741

7.  Pharmacokinetics in plasma and alveolar regions of healthy calves subcutaneously administered a single dose of enrofloxacin.

Authors:  Tetsuro Kuramae; Konosuke Otomaru; Masaya Hirata; Shingo Ishikawa; Michiko Noguchi; Tomonobu Ikedo; Chie Horinouchi; Jun Hayashi; Keita Tsumagari; Seiji Hobo
Journal:  J Vet Med Sci       Date:  2020-07-19       Impact factor: 1.267

8.  Decontamination of mycoplasma-contaminated Orientia tsutsugamushi strains by repeating passages through cell cultures with antibiotics.

Authors:  Motohiko Ogawa; Tsuneo Uchiyama; Masaaki Satoh; Shuji Ando
Journal:  BMC Microbiol       Date:  2013-02-08       Impact factor: 3.605

Review 9.  Mycoplasma bovis: Mechanisms of Resistance and Trends in Antimicrobial Susceptibility.

Authors:  Inna Lysnyansky; Roger D Ayling
Journal:  Front Microbiol       Date:  2016-04-27       Impact factor: 5.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.